Navigation Links
Vertebral Technologies, Inc. Crosses 3,000 Implant Milestone for Market-Leading InterFuse® Interbody Devices
Date:8/9/2013

Minnetonka, MN (PRWEB) August 09, 2013

Vertebral Technologies, Inc. (VTI), an industry leader in innovative spinal fusion implants, announced today that more than 3,000 InterFuse® interbody fusion devices have been implanted, including the InterFuse S™ and the InterFuse T™. Both devices use the company’s revolutionary interlocking modular technology to implant a large ALIF-sized implant through a small, single posterior or transforaminal incision.

Chairman and CEO, Jeffrey Felt, MD stated: "The continued sales growth and increasing number of surgeon users proves the superiority of our technology. By providing a large implant through a less-invasive approach, we give surgeons and patients the best lumbar fusion option available. We continue our innovative approach to improving spinal therapies through less-invasive approaches and will be bringing two more fusion devices to market in coming months. Additionally, we are very excited about the potential of our InterCushion®, a new motion preserving device that is currently in clinical trial in Canada."

About the InterFuse© Interbody System:

The InterFuse© Interbody System are a pair of modular devices consisting of an integral rail-and-slot multi-segmental system. This system allows the surgeon to customize the width of the device through a less invasive (even minimally invasive) unilateral approach, and it allows for full endplate coverage, similar to an ALIF-approach. The InterFuse T™ and InterFuse S™ are soon to be joined by two more devices to complete the family: the InterFuse T-Duo™ is a second TLIF device and the InterFuse L™ will allow a lateral approach with the benefits of full endplate coverage achieved with a modular device delivered through an MIS tube or a mini-open approach.    

About Vertebral Technologies, Inc:

Vertebral Technologies, Inc. is a privately held company dedicated to the design, development, manufacturing and marketing of medical devices to address painful conditions of the spine through less-invasive surgical approaches.

Vertebral Technologies, Inc. anticipates continued growth through the remainder of 2013.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11008043.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment Research Report
2. Document Management Solution Globodox by ITAZ Technologies, Celebrates World Environment Day
3. Citel Technologies, Inc. Announces Firmware Release 6.01.0 for its Portico™ TVA™
4. UV Technologies, Makers of UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in Northern Hemisphere as Available Daylight Increases
5. Albright Technologies, the Leader in Medical Silicone Molding, Appoints New President
6. Research and Markets - Drug Delivery in Cancer - Technologies, Markets and Companies - 2013 Report
7. Nano drug crosses blood-brain tumor barrier, targets brain-tumor cells and blood vessels
8. E-Store India Crosses the 1-million Mark for Number of Registered Online Buyers
9. A new European network crosses the boundaries for excellence in language and perception research
10. Ethicon Vaginal Mesh Lawsuits Continue, as Claims in New Jersey Litigation Exceed 3,000, Bernstein Liebhard LLP Reports
11. Connecticut Community for Addiction Recovery Pays Tribute to Volunteers at 8th Annual Recognition Celebration: Community Members Honored For 23,000 Hours of Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: